FEops Partners with TeraRecon to Scale the Commercialization of FEops HEARTguide, its Digital Twin Solution for an Elevated Structural Heart Experience
FEops, a leader in personalized predictive planning for structural heart interventions, announced today its partnership with ConcertAI's TeraRecon, for the commercialization of FEops HEARTguide’s for Left Atrial Appendage (LAA) occlusion workflow, with a strong focus on the US market.